# Co-Innovation Biotech Co., Ltd.

# Section 5 - 510(k) Summary

Date of Summary Preparation: 12/30/2013

# 1. Submitter's Identifications

Submitter: Co-Innovation Biotech Co.,Ltd.   
Address: No.13, Yanyuan Road, Tianhe District, Guangzhou, P.R. China Contact Person: Hong Feng   
Contact Email Address: fenghongfda@126.com   
Telephone: + 86 -20-62867285   
Fax: + 86 -20-62867285

# 2. Correspondent's Identifications

Correspondent's Name: Co-Innovation Biotech Co.,Ltd.   
Address: No.13, Yanyuan Road, Tianhe District, Guangzhou, P.R. China Contact Person: Hong Feng   
Contact Email Address: fenghongfda@126.com   
Telephone: $+ ~ 8 6$ -20-62867285   
Fax: + 86 -20-62867285

# 3. Name of the Device

Recommended classification regulation:

21 CFR 862.3100   
21 CFR 862.3610   
21 CFR 862.3250   
21 CFR 862.3870   
21 CFR 862.3640

Device class: Class II   
Panel: Toxicology (91)   
Product code: DKZ,DJC,DIO,LDJ,DKN

Common Name:

Amphetamine Test System Methamphetamine Test System Cocaine Test System Cannabinoid Test System Morphine Test System

. Proprietary names:

One Step Single/Multi-drug Test Cup One Step Single/Multi-drug Test Dipcard

# Co-Innovation Biotech Co., Ltd.

# 4 The Predicate Devices

K091588

UCP HomeTM Drug Screening Test Cards UCP Home™M Drug Screening Test Cup

# 5. Device Description

One Step Single/Multi-drug Test Cup and One Step Single/Multi-drug Test Dipcard are competitive binding, lateral flow immunochromatographic assays for qualitatively the detection of Amphetamine, Cocaines, Marijuana, Methamphetamine,Morphine and their metabolites at or above the cut-off levels as indicated. The tests can be performed without the use of an instrument.

# 6. Intended Use of Device

One Step Single/Multi-drug Test Cup and One Step Single/Multi-drug Test Dipcard are lateral flow chromatographic immunoassay designed to qualitatively detect the presence of drugs and drug metabolites in human urine at the following cut-off concentrations:

<table><tr><td rowspan=1 colspan=1>Test</td><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Cut-off level</td></tr><tr><td rowspan=1 colspan=1>Marijuana (THC)</td><td rowspan=1 colspan=1>Delta-9-THC-COOH</td><td rowspan=1 colspan=1>50 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Cocaine (COC)</td><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>300 ng/ml</td></tr><tr><td rowspan=1 colspan=1>Amphetamine (AMP)</td><td rowspan=1 colspan=1>D-Amphetamine</td><td rowspan=1 colspan=1>1000 ng/ml.</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine (MET)</td><td rowspan=1 colspan=1>D-Methamphetamine</td><td rowspan=1 colspan=1>1000 ng/ml</td></tr><tr><td rowspan=1 colspan=1>Morphine 2000 (MOP)</td><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>2000 ng/mL           .</td></tr></table>

The tests contain two formats: 1) Test Cup, 2) Test Dipcard, The test configuration comes with single drug screening test or any combinations of multiple drug screening tests. The test is intended for in vitro diagnostics use. They are intended for prescription use in clinical laboratories only and not for point-of-care use.

This assay provides only a preliminary analytical test result. Gas Chromatography/Mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

# 7. Comparison to Predicate Devices:

A summary comparison of features of the One Step Single/Multi-drug Test Cup and One Step Single/Multi-drug Test Dipcard and the predicate devices is provided in the following Table:

# Co-Innovation Biotech Co., Ltd.

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate (K091588)</td></tr><tr><td rowspan=1 colspan=1>Indication for use</td><td rowspan=1 colspan=1>Qualitative detection ofdrugs-of-abuse in urine(Cocaine ,Morphine,Methamphetamine,Amphetamine,Marijuana</td><td rowspan=1 colspan=1>Same (but the number of drugsdetected different)</td></tr><tr><td rowspan=1 colspan=1>Intended Users</td><td rowspan=1 colspan=1>Prescription Use</td><td rowspan=1 colspan=1>Over the Counter (OTC) Useand Prescription Use</td></tr><tr><td rowspan=1 colspan=1>Specimen</td><td rowspan=1 colspan=1>Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>Cocaine:300 ng/mLMethamphetamine:1000 ng/mLAmphetamine:1000 ng/mLMorphine:2000 ng/mLMarijuana:50 ng/mL</td><td rowspan=1 colspan=1>Cocaine:300 ng/mLMethamphetamine: 1000 ng/mLAmphetamine:1000 ng/mLMorphine:300 ng/mLMarijuana:50 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Read time</td><td rowspan=1 colspan=1>5 minutes</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Storage</td><td rowspan=1 colspan=1>4~30 °C</td><td rowspan=1 colspan=1>2~30 </td></tr><tr><td rowspan=1 colspan=1>Results</td><td rowspan=1 colspan=1>Qualitative</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, Lateralflow immunochromatographicassay based on the principle ofantigen antibodyimmunochemistry</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Configuration</td><td rowspan=1 colspan=1>Dipcard and Cup</td><td rowspan=1 colspan=1>Card and Cup</td></tr></table>

# Remark:

The subject devices have all features of the predicate device except the number of drugs detected, the cutoff of Morphine and storage temperature condition different. These differences do not affect the performance characteristics of the subject devices.

# 8. Performance Data:

# Accuracy

Single drug Test:

165-186 clinical urine specimens for each drug were analyzed by GC/MS and by one lot of the corresponding One Step Single drug Test Cup. Samples were divided by concentration into five categories:drug free, less than half the cutoff, near cutoff negative, near cutoff positive, and high positive. Results were as follows:

<table><tr><td rowspan=1 colspan=1>DrugTest</td><td rowspan=1 colspan=1>Co-InnovationResult</td><td rowspan=1 colspan=1>Orug free by GC/MSanalysis</td><td rowspan=1 colspan=1>Less than half thecutoff concentrationby GC/MS analysis</td><td rowspan=1 colspan=1>Near Cutoff Negative(Between 50% below thecutoff and the cutoffconcentration)</td><td rowspan=1 colspan=1>Near Cutoff Positive(Between the cutoffand 50% above thecutoff concentration)</td><td rowspan=1 colspan=1>High Positive(greater than 50%above the cutoffconcentration)</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>AMP</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>29</td><td rowspan=2 colspan=1>176</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>117</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>COC</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>31</td><td rowspan=2 colspan=1>186</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>133</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>THC</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>31</td><td rowspan=2 colspan=1>165</td></tr><tr><td rowspan=1 colspan=1>.</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

# Co-Innovation Biotech Co., Ltd.

<table><tr><td rowspan=2 colspan=1>MET</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>44</td><td rowspan=2 colspan=1>165</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>85</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>MOP</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>57</td><td rowspan=2 colspan=1>165</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>67</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Analysis of Discordant Results with One Step Single drug Test Cup   

<table><tr><td rowspan=1 colspan=3>One Step Single drug Test Cup</td><td rowspan=1 colspan=2>GC/MSAnalysis</td></tr><tr><td rowspan=1 colspan=1>Drug Test</td><td rowspan=1 colspan=1>Cutoff(ng/mL)</td><td rowspan=1 colspan=1>Test Result</td><td rowspan=1 colspan=1>DrugConcentration(ng/ml)</td><td rowspan=1 colspan=1>Drug in Urine</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>867</td><td rowspan=1 colspan=1>Amphetamine</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1175</td><td rowspan=1 colspan=1>Amphetamine</td></tr><tr><td rowspan=1 colspan=1>COc</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>172</td><td rowspan=1 colspan=1>Benzoylecgonine</td></tr><tr><td rowspan=1 colspan=1>MET</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>904</td><td rowspan=1 colspan=1>Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>MET</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1248</td><td rowspan=1 colspan=1>Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>MOP</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>Posilive</td><td rowspan=1 colspan=1>1608</td><td rowspan=1 colspan=1>Morphine</td></tr><tr><td rowspan=1 colspan=1>MOP</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>1875</td><td rowspan=1 colspan=1>Morphine</td></tr><tr><td rowspan=1 colspan=1>THC</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td></tr><tr><td rowspan=1 colspan=1>THC</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td></tr></table>

165-186 clinical urine specimens for each drug were analyzed by GC/MS and by one lot of the corresponding One Step Single drug Test Dipcard. Samples were divided by concentration into v catridug ees than al the uto ner cutoff eati, ner cuto posiiv nd high positive. Results were as follows:

<table><tr><td rowspan=1 colspan=1>DrugTest</td><td rowspan=1 colspan=1>Co-InnovationResult</td><td rowspan=1 colspan=1>Drug free by GC/MSanalysis</td><td rowspan=1 colspan=1>Less than half thecutoff concentrationby GC/MS analysis</td><td rowspan=1 colspan=1>Near Cutoff Negative(Between 50% below thecutoff and the cutoffconcentration)</td><td rowspan=1 colspan=1>Near Cutoff Positive(Between the cutoffand 50% above thecutoff concentration)</td><td rowspan=1 colspan=1>High Positive(greater than 50%above the cutoffconcentration)</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>AMP</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>29</td><td rowspan=2 colspan=1>176</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>117</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>coc</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>Q</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>31</td><td rowspan=2 colspan=1>186</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>133</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>THC</td><td rowspan=1 colspan=1>*</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>31</td><td rowspan=2 colspan=1>165</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=4 colspan=1>MET</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>44</td><td></td></tr><tr><td rowspan=3 colspan=1>.</td><td rowspan=3 colspan=1>85</td><td rowspan=3 colspan=1>4</td><td rowspan=3 colspan=1>13</td><td rowspan=3 colspan=1>1</td><td></td><td></td></tr><tr><td></td><td rowspan=2 colspan=1>165</td></tr><tr><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>MOP</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>57</td><td rowspan=2 colspan=1>165</td></tr><tr><td rowspan=1 colspan=1>.</td><td rowspan=1 colspan=1>67</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Analysis of Discordant Results with One Step Single drug Test Dipcard   

<table><tr><td rowspan=1 colspan=3>One Step Single drug Test Dipcard</td><td rowspan=1 colspan=2>GC/MS Analysis</td></tr><tr><td rowspan=1 colspan=1>Drug Test</td><td rowspan=1 colspan=1>Cutoff(ng/mL)</td><td rowspan=1 colspan=1>Test Result</td><td rowspan=1 colspan=1>DrugConcentration(ng/mL)</td><td rowspan=1 colspan=1>Drug in Urine</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>867</td><td rowspan=1 colspan=1>Amphetamine</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1175</td><td rowspan=1 colspan=1>Amphetamine</td></tr><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>172</td><td rowspan=1 colspan=1>Benzoylecgonine</td></tr><tr><td rowspan=1 colspan=1>MET</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>904</td><td rowspan=1 colspan=1>Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>MET</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1248</td><td rowspan=1 colspan=1>Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>MOP</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>1608</td><td rowspan=1 colspan=1>Morphine</td></tr><tr><td rowspan=1 colspan=1>MOP</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>1875</td><td rowspan=1 colspan=1>Morphine</td></tr><tr><td rowspan=1 colspan=1>THC</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td></tr><tr><td rowspan=1 colspan=1>THC</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td></tr></table>

Multi-drug Test:

80 clinical urine specimens or each drug were analyzed by GC/MS and by one lot of the corresponding One Step Multi-drug Test Cup. Samples were divided by concentration into five categories:drug free, less than half the cutoff near cutoff negative, near cutoff positive, and high positive. Results were as follows:

# Co-Innovation Biotech Co., Ltd.

<table><tr><td rowspan=1 colspan=1>DrugTest</td><td rowspan=1 colspan=1>Co-innovationResult</td><td rowspan=1 colspan=1>Drug free by GC/MSanalysis</td><td rowspan=1 colspan=1>Less than half thecutoff concentrationby GC/MS analysis</td><td rowspan=1 colspan=1>Near Cutoff Negative(Between 50% below thecutoff and the cutoffconcentration)</td><td rowspan=1 colspan=1>Near Cutoff Positive(Between the cutoffand 50% above thecutoff concentration)</td><td rowspan=1 colspan=1>High Positive(greater than 50%above the cutoffconcentration)</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>AMP</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>29</td><td rowspan=2 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>COC</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>31</td><td rowspan=2 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>THC</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>27</td><td rowspan=2 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>MET</td><td rowspan=1 colspan=1>*</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>27</td><td rowspan=2 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>MOP</td><td rowspan=1 colspan=1>×</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>29</td><td rowspan=2 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>*</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Analysis of Discordant Results with One Step Multi-drug Test Cup   

<table><tr><td rowspan=1 colspan=3>One Step Multi-drug Test Cup</td><td rowspan=1 colspan=2>GC/MSAnalysis</td></tr><tr><td rowspan=1 colspan=1>Drug Test</td><td rowspan=1 colspan=1>Cutoff(ng/mL)</td><td rowspan=1 colspan=1>Test Result</td><td rowspan=1 colspan=1>DrugConcentration(ng/mL)</td><td rowspan=1 colspan=1>Drug in Urine</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>867</td><td rowspan=1 colspan=1>Amphetamine</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1175</td><td rowspan=1 colspan=1>Amphetamine</td></tr><tr><td rowspan=1 colspan=1>Coc</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>172</td><td rowspan=1 colspan=1>Benzoylecgonine</td></tr><tr><td rowspan=1 colspan=1>MET</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>904</td><td rowspan=1 colspan=1>Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>MET</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1248</td><td rowspan=1 colspan=1>Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>MOP</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>1608</td><td rowspan=1 colspan=1>Morphine</td></tr><tr><td rowspan=1 colspan=1>MOP</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>Posilive</td><td rowspan=1 colspan=1>1875</td><td rowspan=1 colspan=1>Morphine</td></tr><tr><td rowspan=1 colspan=1>THC</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td></tr><tr><td rowspan=1 colspan=1>THC</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td></tr></table>

80 clinical urine specimens for each drug were analyzed by GC/MS and by one lot of the corresponding One Step Multi-drug Test Dipcard. Samples were divided by concentration into five cat ee than l thec, ner cf tv, ner cof osiv, and h positive. Results were as follows:

<table><tr><td rowspan=1 colspan=1>DrugTest</td><td rowspan=1 colspan=1>Co-InnovationResult•</td><td rowspan=1 colspan=1>Drug free by GC/MSanalysis</td><td rowspan=1 colspan=1>Less than half thecutoff concentrationby GC/MS analysis</td><td rowspan=1 colspan=1>Near Cutoff Negative(Between 50% below thecutoff and the cutoffconcentration)</td><td rowspan=1 colspan=1>Near Cutoff Positive(Between the cutoffand 50% above thecutoff concentration)</td><td rowspan=1 colspan=1>High Positive(greater than 50%above the cutoffconcentration)</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>AMP</td><td rowspan=1 colspan=1>*</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>29</td><td rowspan=2 colspan=1>B0</td></tr><tr><td rowspan=1 colspan=1>•</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=4 colspan=1>coc</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>31</td><td></td></tr><tr><td></td><td></td><td></td><td rowspan=3 colspan=1>12</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td rowspan=2 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=4 colspan=1>THC</td><td rowspan=1 colspan=1>*</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>27</td><td></td></tr><tr><td rowspan=3 colspan=1>-</td><td rowspan=3 colspan=1>26</td><td rowspan=3 colspan=1>4</td><td rowspan=3 colspan=1>9</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td rowspan=2 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=3 colspan=1>MET</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>27</td><td></td></tr><tr><td rowspan=2 colspan=1>-</td><td rowspan=2 colspan=1>24</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>13</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>0</td><td></td></tr><tr><td rowspan=1 colspan=1>80</td></tr><tr><td rowspan=4 colspan=1>MOP</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>29</td><td></td></tr><tr><td rowspan=3 colspan=1>•</td><td rowspan=3 colspan=1>21</td><td rowspan=3 colspan=1>2</td><td rowspan=3 colspan=1>15</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td rowspan=2 colspan=1>80</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Analysis of Discordant Results with One Step Multi-drug Test Dipcard   

<table><tr><td rowspan=1 colspan=3>One Step Multi-drug Test Dipcard</td><td rowspan=1 colspan=2>GC/MSAnalysis</td></tr><tr><td rowspan=1 colspan=1>Drug Test</td><td rowspan=1 colspan=1>Cutoff(ng/mL)</td><td rowspan=1 colspan=1>Test Result</td><td rowspan=1 colspan=1>DrugConcentration(ngL)</td><td rowspan=1 colspan=1>Drug in Urine</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>867</td><td rowspan=1 colspan=1>Amphetamine</td></tr><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1175</td><td rowspan=1 colspan=1>Amphetamine</td></tr><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>172</td><td rowspan=1 colspan=1>Benzoylecgonine</td></tr><tr><td rowspan=1 colspan=1>MET</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>904</td><td rowspan=1 colspan=1>Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>MET</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1248</td><td rowspan=1 colspan=1>Methamphetamine</td></tr><tr><td rowspan=1 colspan=1>MOP</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>1608</td><td rowspan=1 colspan=1>Morphine</td></tr><tr><td rowspan=1 colspan=1>MOP</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>1875</td><td rowspan=1 colspan=1>Morphine</td></tr><tr><td rowspan=1 colspan=1>THC</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td></tr><tr><td rowspan=1 colspan=1>THC</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td></tr></table>

# Co-Innovation Biotech Co., Ltd.

# Other Information About Performance Characteristics:

The performance characteristics of One Step Single/Multi-drug Test Cup and One Step Single/Multi-drug Test Dipcard were evaluated by precision study, sensitivity study, specificity and cross reactivity study, interference study and stability study. The study results indicate that One Step Single/Multi-drug Test Cup and One Step Single/Multi-drug Test Dipcard perform satisfactorily when used according to the package inserts.

# 10. Conclusion:

One Step Single/Multi-drug Test Cup and One Step Single/Multi-drug Test Dipcard are substantially equivalent to UCP Home™M Drug Screening Test Cards and UCP Home™M Drug Screening Test Cup. .

--- End of this section ---

CO-INNOVATION BIOTECH CO., LTD.HONG FENG, PRODUCT MANAGERNO. 13 YANYUAN ROAD. TIANHE DISTRICTGUANGZHOU, GUANGDONG 510507CH

Re: K131110 Trade/Device Name: One Step Single/Multi-drug Test Cup; One Step Single ingleMultiduTest Dip Regulation Number: 21 CFR 862.3100 Regulation Name: Amphetamine test system Regulatory Class: II Product Code: DKZ, DJC, DKN, LDJ, DIO Dated: January 2, 2014 Received: January 2, 2014

Dear Hong Feng:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device s classified see above) into either class I (Special Controls)or class I (MA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000- 1050.

Page 2- Hong Feng

If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809). please contact the Division of Small Manufacturers. Intermational and Consumer   
Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.hum. Also. please note the regulation entitled., "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803). please go to   
http://www.fda.gov/MedicalDevices/Safetv/ReportaProblem/default.htm for the CDRHl's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address hup://www.Ida.gov/MedicalDevices/ResourcesforYou/Industrv/default.htm.

Sincerely yours.

# Courtney H. Lias -S

Courtney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics   
and Radiological Health   
Center for Devices and Radiological Health

510(k) Number (if known) K131110

Device Name One-Step Single/Muhi-drug Test Cup; One-Step single/multi-drug Test Card

Indications for Use (Describe)

S  u coneentrations:

Test Calibrator Cu-oftlevel Marijuana (THC) Dela-9-THC-COOH 50 ng/ml. Cocaine (COC) Benzoylecgonine 300 ng/ml Amphetam ine (AMP) D-Amphetamine 1000 ng/ml. Methamphetamine (MET) D-Methamphetamine $\mathfrak { i } \left( \mathfrak { N } \right) \left( \mathfrak { N } \mathfrak { g } ^ { \prime } \mathfrak { N } \right) ,$ Morphine 2000 (MOP) Morphine EY $2 0 1 ) 0 1 1 1 1 \vert \because 1 1 1 \vert$ .

Th in clinical laboratories only and not for point-of-care use.

u